Stockscreener 앱 받기
0.88
1.66%
-0.0149
시장 영업 전:
.88
전일 마감가:
$0.8949
열려 있는:
$0.893
하루 거래량:
15,963
Relative Volume:
0.02
시가총액:
$2.37M
수익:
$819.00K
순이익/손실:
$-17.70M
주가수익비율:
-0.0695
EPS:
-12.6647
순현금흐름:
$-8.45M
1주 성능:
+3.77%
1개월 성능:
-6.38%
6개월 성능:
-58.49%
1년 성능:
-75.46%
1일 변동 폭
$0.8374
$0.893
1주일 범위
$0.8374
$0.9397
52주 변동 폭
$0.7501
$15.68
Catheter Precision Inc. Stock (VTAK) Company Profile
명칭
Catheter Precision Inc.
전화
973 691 2000
주소
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.88 | 2.41M | 819.00K | -17.70M | -8.45M | -12.66 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-08-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | 개시 | Maxim Group | Buy |
Catheter Precision Inc. 주식(VTAK)의 최신 뉴스
Catheter Precision Inc. (VTAK) Q1 2025 Earnings: Significant EPS Miss and No Revenue ReportedPost-Earnings Reaction - thelegaladvocate.com
Catheter Precision Company Profile & Introduction - Moomoo
Catheter Precision (VTAK) Q1 2025 Earnings: Significant EPS Miss as Stock Rises Amid Strategic ProgressEPS Miss Report - Newser
Catheter Precision Inc. (VTAK) Gains 5.7% as Micro-Cap Stock Tests Resistance Near $0.88Volatility Breakout Picks - thelegaladvocate.com
VTAK Q1 2025 Earnings: Significant EPS Miss Amidst Operational ChallengesFinancial Data - thelegaladvocate.com
Catheter Precision reports net loss of USD 1.7M in Q1 2026 - Medical Buyer
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND - Yahoo Finance
Catheter Precision (NYSE: VTAK) triples Q1 revenue and adds Flyte aviation - Stock Titan
Catheter Precision, Inc. (VTAK) Q1 2026 10-Q Report: Financials, Warrants, and Segment Details - Minichart
Catheter Precision reports 200% revenue growth in Q1 2026 By Investing.com - Investing.com Nigeria
Catheter Precision reports 200% revenue growth in Q1 2026 - Investing.com
Catheter Precision Announces Brief 10-Q Filing Delay - TipRanks
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION - marketscreener.com
Medical device firm’s Q1 sales jump 200% after Flyte jet deal - Stock Titan
Catheter Precision, Inc. 1Q 2026: Revenue $432K, EPS ($1.39) — 10-Q Summary - TradingView
Catheter Precision: Revenue rose with FLYTE acquisition, but liquidity and dilution risks remain high - TradingView
Catheter Precision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Catheter Precision (NYSE: VTAK) adds aviation unit but flags going concern risk - Stock Titan
Catheter Precision (NASDAQ: VTAK) delays Q1 2026 10-Q after March 9 acquisitions - Stock Titan
Number of shareholders of Catheter Precision, Inc. – FWB:4RM - TradingView
Catheter Precision (VTAK) Q1 2025 Results Miss Estimates — EPS $-6.65 vs $-3.88EBITDA Margin Trends - Newser
VTAK Should I Buy - Intellectia AI
Catheter Precision (VTAK) 13G/A: Affiliates Report 0% Beneficial Ownership - Stock Titan
VTAK Stock Price, Quote & Chart | CATHETER PRECISION INC (NYSEARCA:VTAK) - ChartMill
FLYTE ACTIVATES HIGH-FREQUENCY PREAKNESS FLIGHT PROGRAM, DEPLOYING FLEET TO SERVE STRONG NORTHEAST DEMAND - The Manila Times
Sub-one-hour Preakness flights: Flyte offers I-95 alternative - Stock Titan
What Catheter Precision (VTAK) management is focused on executing | Q1 2025: Below ExpectationsSecondary Offering - newser.com
VTAK: Catheter Precision, Inc.Interactive Chart - Zacks Investment Research
Catheter Precision IncSpirit Airlines Shut - Moomoo
Spirit shutdown hit 17,000 workers; Flyte starts pilot hiring - Stock Titan
Catheter Precision, Inc. 2025 10-K/A Filing: Company Information, Filings Status, and Key Disclosures - Minichart
Catheter Precision : Amendment to Annual Report (Form 10-K/A) - marketscreener.com
Related-party financings reshape Catheter Precision (NYSE: VTAK) structure - Stock Titan
Catheter Precision’s Flyte expands jet fleet for summer routes By Investing.com - Investing.com India
Catheter Precision’s Flyte expands jet fleet for summer routes - Investing.com
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand - Yahoo Finance
New Charter Service Coming to Newport State Airport - Newport This Week
Catheter Precision Raises Capital Through New Preferred Stock - TipRanks
Catheter Precision (NYSE: VTAK) adds $3.47M and Flyte deal stock - Stock Titan
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting - marketscreener.com
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm ... - Bluefield Daily Telegraph
VTAK Catheter Precision shares rise 6.79 percent as 95 percent year over year revenue growth offsets weak Q1 2025 earnings.Expert Breakout Alerts - Xã Thanh Hà
Catheter Precision receives patent allowance for vessel closing device By Investing.com - Investing.com India
Catheter Precision (VTAK) Secures Notice of Allowance for Surgical Device Patent - GuruFocus
Catheter Precision receives patent allowance for vessel closing device - Investing.com
Catheter Precision Secures U.S. Patent Allowance on Foundational Surgical Technology, Establishing Powerful IP and Accelerating Scalable Growth Strategy - The Manila Times
Patent allowance gives LockeT surgical technology broader protection - Stock Titan
Catheter Precision Inc. (VTAK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):